Zenas Biopharma Inc (ZBIO)

Nov 21, 2025

Zenas BioPharma : Corporate Presentation - MarketScreener

Nov 21, 2025

Nov 20, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Zenas BioPharma, Inc. (ZBIO) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire

Nov 20, 2025

Nov 20, 2025

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Zenas BioPharma, Inc. (NASDAQ: ZBIO) - PR Newswire

Nov 20, 2025

Nov 20, 2025

Will Zenas BioPharma Inc. benefit from macro trendsEarnings Beat & Verified High Yield Trade Plans - newser.com

Nov 20, 2025

Nov 20, 2025

Is Zenas BioPharma Inc. stock a dividend growth opportunityDollar Strength & High Conviction Investment Ideas - newser.com

Nov 20, 2025

Nov 20, 2025

Will Zenas BioPharma Inc. stock keep outperforming rivalsMarket Sentiment Summary & Verified Technical Trade Signals - newser.com

Nov 20, 2025

Nov 20, 2025

Will Zenas BioPharma Inc. stock remain a Wall Street favoriteEarnings Performance Report & Risk Controlled Swing Alerts - newser.com

Nov 20, 2025

Nov 20, 2025

What analysts say about Zenas BioPharma Inc stockMomentum Trading Signals & Low Cost Market Strategies - earlytimes.in

Nov 20, 2025

Nov 19, 2025

Bronstein, Gewirtz & Grossman, LLC Encourages Zenas BioPharma, Inc. (ZBIO) Stockholders to Inquire about Securities Investigation - ACCESS Newswire

Nov 19, 2025

Nov 19, 2025

What dividend safety score for Zenas BioPharma Inc. stockTrade Exit Summary & Long Hold Capital Preservation Tips - newser.com

Nov 19, 2025

Nov 19, 2025

Price momentum metrics for Zenas BioPharma Inc. explainedBuy Signal & Fast Moving Stock Watchlists - newser.com

Nov 19, 2025

Nov 19, 2025

From Olema To Insmed: Are These High-Flying Biotechs Still Worth Buying? - RTTNews

Nov 19, 2025

Nov 18, 2025

Strategies to average down on Zenas BioPharma Inc.2025 Market Sentiment & Stepwise Entry/Exit Trade Alerts - newser.com

Nov 18, 2025

Nov 18, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating Zenas BioPharma, Inc. (ZBIO) And Encourages Shareholders to Connect - ACCESS Newswire

Nov 18, 2025

Nov 18, 2025

2025-11-18 | Bronstein, Gewirtz & Grossman, LLC Is Investigating Zenas BioPharma, Inc. (ZBIO) And Encourages Shareholders to Connect | NDAQ:ZBIO | Press Release - Stockhouse

Nov 18, 2025

Nov 17, 2025

Zenas Biopharma stock hits all-time high at 36.7 USD By Investing.com - Investing.com Nigeria

Nov 17, 2025

Nov 17, 2025

Zenas BioPharma (ZBIO) Price Target Increased by 10.51% to 44.44 - Nasdaq

Nov 17, 2025

Nov 17, 2025

Will Zenas BioPharma Inc. stock sustain high P E ratiosMarket Sentiment Report & Daily Stock Trend Reports - newser.com

Nov 17, 2025

Nov 16, 2025

2025-11-16 | Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Zenas BioPharma, Inc. (ZBIO) And Encourages Shareholders to Reach Out | NDAQ:ZBIO | Press Release - Stockhouse

Nov 16, 2025

Nov 16, 2025

How risky is Zenas BioPharma Inc. stock nowBull Run & Real-Time Chart Breakout Alerts - newser.com

Nov 16, 2025

Nov 15, 2025

Is Zenas BioPharma Inc. stock ready for breakoutEarnings Growth Report & Expert Verified Movement Alerts - newser.com

Nov 15, 2025

Nov 15, 2025

Published on: 2025-11-15 02:01:43 - newser.com

Nov 15, 2025

Nov 14, 2025

Zenas BioPharma Reports Q3 2025 Financial Results - TipRanks

Nov 14, 2025

Nov 14, 2025

How to track smart money flows in Zenas BioPharma Inc.Trade Risk Report & Safe Entry Trade Signal Reports - newser.com

Nov 14, 2025

Nov 14, 2025

How Zenas BioPharma Inc. stock reacts to inflationary pressuresGap Down & Free Long-Term Investment Growth Plans - newser.com

Nov 14, 2025

Nov 13, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Zenas BioPharma, Inc. (ZBIO) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire

Nov 13, 2025

Nov 13, 2025

Zenas BioPharma price target raised to $37 from $34 at Morgan Stanley - TipRanks

Nov 13, 2025

Nov 13, 2025

Zenas BioPharma, Inc.: Promising Outlook with Positive Clinical Results and Strong Financial Position Supporting Buy Rating - TipRanks

Nov 13, 2025

Nov 13, 2025

Decoding Zenas BioPharma Inc (ZBIO): A Strategic SWOT Insight - GuruFocus

Nov 13, 2025

Nov 12, 2025

Zenas BioPharma, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2025 - MarketScreener

Nov 12, 2025

Nov 12, 2025

Zenas BioPharma Q3 Net Loss Narrows - MarketScreener

Nov 12, 2025

Nov 12, 2025

Earnings Flash (ZBIO) Zenas BioPharma Posts Q3 Net Loss $1.22 a Share, vs. FactSet Est of $0.83 Loss - MarketScreener

Nov 12, 2025

Nov 12, 2025

Zenas BioPharma, Inc. SEC 10-Q Report - TradingView

Nov 12, 2025